Processa Pharmaceuticals, Inc.
NASDAQ: PCSA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- George K. Ng
- Employees
- 10
- Headquarters
- Hanover, United States
- IPO year
- 2014
- Market cap
- $4.4M
- Website
- https://www.processapharmaceuticals.com
Loading PCSA…
Loading profile data…Frequently asked questions about PCSA
What does Processa Pharmaceuticals, Inc. (PCSA) do?
Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States. The company's leading investigational drug, PCS499, is an oral tablet presently undergoing Phase 2B clinic...
Where does PCSA trade?
Processa Pharmaceuticals, Inc. (PCSA) trades on the NASDAQ Capital Market.
What sector is PCSA in?
Processa Pharmaceuticals, Inc. (PCSA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Processa Pharmaceuticals, Inc.?
George K. Ng is the chief executive officer of Processa Pharmaceuticals, Inc. (PCSA).
Where is Processa Pharmaceuticals, Inc. headquartered?
Processa Pharmaceuticals, Inc. is headquartered in United States.
Does PCSA pay a dividend?
Processa Pharmaceuticals, Inc. (PCSA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PCSA go public?
Processa Pharmaceuticals, Inc. (PCSA) completed its initial public offering in 2014.